Michael DiPrima, Ph.D.
- Center for Cancer Research
- National Cancer Institute
- 37/4124
- Bethesda, MD 20892
- 240 760 7912
- michael.diprima@nih.gov
RESEARCH SUMMARY
Dr. DiPrima’s research is focused on the identification of vulnerabilities in colorectal cancer cells, particularly emerging from Eph receptors activation and tyrosine kinase signaling. Currently, he is exploring small molecule inhibitors to inhibit cancer cell growth.
Areas of Expertise
1) cancer cells 2) tyrosine kinase receptors 3) ephrin ligands and Eph receptors 4) mouse models of cancer 5) tyrosine kinase inhibitors